Terms: = Breast cancer AND ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR-1, MXR1, UAQTL1 AND Staging
4 results:
1. Association of abcg2 Polymorphisms on Triple Negative breast cancer (TNBC) Susceptibility Risk.
Hao Ing Y; Md Salleh MS; Yahya MM; Ankathil R; Abdul Aziz AA
Asian Pac J Cancer Prev; 2023 Nov; 24(11):3891-3897. PubMed ID: 38019248
[TBL] [Abstract] [Full Text] [Related]
2. [Correlation between the mRNA levels of bcrp and LUNX genes and pathological types and stages of patients with non-small cell lung cancer].
Chen D; Han W; Wang P; Ma H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Feb; 40(2):202-207. PubMed ID: 36709941
[TBL] [Abstract] [Full Text] [Related]
3. [Expression of FoxM1 and bcrp in invasive breast carcinoma of no special type and its prognosis significance].
Liu Y; Liu YP; Liu JY; Yang HC; Wang ZD
Zhonghua Bing Li Xue Za Zhi; 2017 Jan; 46(1):30-33. PubMed ID: 28072973
[No Abstract] [Full Text] [Related]
4. Expression of drug pathway proteins is independent of tumour type.
Zhang W; Shannon WD; Duncan J; Scheffer GL; Scheper RJ; McLeod HL
J Pathol; 2006 Jun; 209(2):213-9. PubMed ID: 16508919
[TBL] [Abstract] [Full Text] [Related]
